Of note, recent guidance from the American Society of Clinical Oncology (ASCO) has recommended testing for BRCA1 and BRCA2 in all BC cases up to the age of 65, including those diagnosed historically [23]. The gene discussed is BRCA1; the disease is breast cancer.